Sponsor or institution
Clinical trials and research at Integral Molecular
As of November 12, 2026, Find a Trial lists 8 NIH-funded research projects at this institution, with $6.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8NIH research projects
NIH-funded research (8)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Specificity screening tool to improve biotherapeutic safety
A new lab test helps check if antibody and CAR-T therapies might bind to unintended parts of the body, aiming to prevent safety problems before medicines reach patients.
-
High-throughput discovery of antibodies for hard-to-study membrane proteins
A NIH grant aims to create and test many monoclonal antibodies against important but understudied membrane proteins to help research and potential therapies.
-
Finding antibodies for understudied cell-surface proteins using mRNA
This project uses mRNA to produce hard-to-study cell-surface proteins so researchers can find antibodies that might lead to new tests or treatments for people affected by those proteins.
-
Identifying how antibodies protect against certain viral infections
This study is looking at how our immune system's antibodies recognize certain parts of Enterovirus and Bunyavirus, which could help create better vaccines and treatments for everyone.
-
Creating Fast and Safe Tests for Viruses like COVID-19
This project aims to create a quicker and safer lab test to measure how well antibodies protect against viruses, including those that cause pandemics.
-
Creating faster and safer tests for viruses like COVID-19
This study is working on a new virus test that helps quickly and safely check how well antibodies fight off viruses like COVID-19, making it easier for researchers to get faster results for vaccine trials and other important health studies.
-
Developing a tool to improve the safety of biotherapeutic drugs
This study is working on a new way to make sure that certain advanced treatments for diseases, like monoclonal antibodies and CAR-T cell therapies, are safer by using a special tool to better understand how they interact with the body, which could help prevent problems before they happen.
-
Creating antibodies to study immune responses in less common animal models
This study is working on creating special antibodies to help scientists learn more about how the immune system works in certain animals that are similar to humans, which could lead to better treatments for diseases that affect us.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.